insights_auto
Why is PTX down 3.03%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.064
arrow_downward
-3.03%(-0.0020) 1D
Oct 5, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.19M
Volume
0.00
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.19M
Volume
0.00
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
bloomingbit
·
14 minutes ago
New York Stocks Close Higher, Nasdaq Gains 1.05%
24/7 Wall St.
·
9 minutes ago
S&P 500 closes at 7,787 as Nasdaq leads broad market higher
TradingView
·
24 minutes ago
Wall Street finished on top as the Nasdaq tagged a record high
Seeking Alpha
·
9 minutes ago
Current S&P 500 Vs. Dot-Com Bubble: Lack Of Breadth Worries Me Most (SP500)
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com